What is Citigroup's price target for LX?

Citigroup's latest stated price target for LexinFintech Holdings Ltd. (LX) is $1.20, from its action on Sep 1, 2026.

What is Citigroup's rating on LX?

Citigroup rates LX Neutral, a neutral rating, as of Sep 1, 2026.

When did Citigroup last change its view on LX?

On Sep 1, 2026, Citigroup downgrades to Neutral from Buy, price target $1.20.

Citigroup LX price target and rating history

LexinFintech Holdings Ltd. (LX) · Finance

Citigroup rates LexinFintech Holdings Ltd. (LX) Neutral with a $1.20 price target, as of its latest action on Sep 1, 2026. It has published 5 rating actions on LX since May 2022, including 2 upgrades and 3 downgrades.

Current rating: Neutral
Price target: $1.20
Median target, all firms: Too few
Actions on LX: 5

Citigroup price target on LX

Citigroup price target on LX, each point a stated target, March 2023 to September 2026.

Every Citigroup rating on LX

Sep 1, 2026
DowngradeCitigroup downgrades to Neutral from Buy, price target $1.20
Nov 26, 2024
UpgradeCitigroup upgrades to Buy from Neutral
Nov 24, 2023
DowngradeCitigroup downgrades to Neutral from Buy
Mar 14, 2023
UpgradeCitigroup upgrades to Buy from Neutral, price target $2.31 to $3.60
May 31, 2022
DowngradeCitigroup downgrades to Neutral from Buy

How other firms rate LX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Citigroup	Neutral	$1.20	Sep 1, 2026
UBS	Neutral	$3.50	Dec 4, 2025

Questions about Citigroup and LX

What is Citigroup's price target for LX?: Citigroup's latest stated price target for LexinFintech Holdings Ltd. (LX) is $1.20, from its action on Sep 1, 2026.
What is Citigroup's rating on LX?: Citigroup rates LX Neutral, a neutral rating, as of Sep 1, 2026.
When did Citigroup last change its view on LX?: On Sep 1, 2026, Citigroup downgrades to Neutral from Buy, price target $1.20.

More LX rating histories

UBS3

All Citigroup ratings LX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.